MOL ONCOL 润色咨询

Molecular Oncology

出版年份:2007 年文章数:1571 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:1.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2023-07-26 156GRoK0535(apple) 来自福建省

    偏重的研究方向:分子;肿瘤
    经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?

    8

    展开8条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2024-01-11 紫在川上 来自重庆

    投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2023-07-18 玉米心儿 来自上海

    今天收到Major revision,审稿时间两个月,祈祷好运。

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2023-08-07 blwu 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2023-08-27 ms4000000347487185 来自辽宁省

    求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2023-08-17 1240adaem89暂无昵称 来自四川省

    想请问一下这个杂志awaiting AE assignment要多久呀?

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2020-08-19 zhanyu

    Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2023-08-01 ms1000000321922839

    建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。

    2

    展开2条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2023-07-18 WX631576466 来自广西

    审稿速度:3.0 | 投稿命中率:95.0
    偏重的研究方向:肿瘤
    经验分享:3个月录用接受

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2149859, encodeId=ddb9214985978, content=偏重的研究方向:分子;肿瘤<br>经验分享:这杂志也太坑了,一审二审大修小修补实验,历时一年多,提交材料,一句图片问题就拒了,要拒早拒啊,太坑人了,这不是毁人吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLjia4Xm8p9qwoayEDGzB26Erpqzydtfib1gDf8u0HDO7icSHxvgOpMXdNficcXHibgAIwgIvBmkicQ4MpA/132, createdBy=36c35177966, createdName=156GRoK0535(apple), createdTime=Wed Jul 26 00:09:53 CST 2023, time=2023-07-26, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2180785, encodeId=9cf22180e8539, content=投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:2023年8月中旬投稿Review一篇,一个半月收到Major Revision,返修回去后2个月接受,历时4个月。整体感觉杂志审稿水平较高,审稿人非常专业,要求较严格,送审速度也非常快。想请问该杂志on line后多久被WOS收录?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=48182029533, createdName=紫在川上, createdTime=Thu Jan 11 14:40:50 CST 2024, time=2024-01-11, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2148705, encodeId=4af92148e05a2, content=今天收到Major revision,审稿时间两个月,祈祷好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53dd5395184, createdName=玉米心儿, createdTime=Tue Jul 18 23:29:05 CST 2023, time=2023-07-18, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2151589, encodeId=3d6f2151589c0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:请问在这个杂志,如何提交WB的原始图片? 每个图都必须有泳道的标记吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34fa4692405, createdName=blwu, createdTime=Mon Aug 07 10:31:26 CST 2023, time=2023-08-07, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2154790, encodeId=980b2154e9070, content=求问外审需要多久啊,综述目前外审已经一个月了还有多久可以结束, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ca38121660, createdName=ms4000000347487185, createdTime=Sun Aug 27 13:14:47 CST 2023, time=2023-08-27, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2153242, encodeId=e6e02153242be, content=想请问一下这个杂志awaiting AE assignment要多久呀?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=df182456760, createdName=1240adaem89暂无昵称, createdTime=Thu Aug 17 15:34:47 CST 2023, time=2023-08-17, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=811226, encodeId=41e38112267d, content=Awaiting AE Assignment,同时有EIC和3个ADM,以为着什么马上under review?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c01577709, createdName=zhanyu, createdTime=Wed Aug 19 23:47:38 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150760, encodeId=22a42150e6049, content=建议慎投,一审大修,二审(2同意发表,1问题较多),直接拒了,文章明明按问题多的审稿人解决了,二审的时候还提出来,编辑也不仔细看,反正一言难尽。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff056514044, createdName=ms1000000321922839, createdTime=Tue Aug 01 13:28:33 CST 2023, time=2023-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148692, encodeId=0ea82148692c8, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向:肿瘤<br>经验分享:3个月录用接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Tue Jul 18 23:07:40 CST 2023, time=2023-07-18, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1210767, encodeId=47a11210e67c8, content=4.7 submission 4.12 under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Wed Apr 13 08:03:03 CST 2022, time=2022-04-13, status=1, ipAttribution=)]
    2022-04-13 H·D·E

    4.7 submission 4.12 under review

    13

    展开13条回复
共230条页码: 1/23页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分